$FOLD News Apple sets intraday record; PetSmart

New Post Public Reply Private Reply Replies (0) Message Board

Aug 30, 2014 at 10:28 AM

$FOLD News

Apple sets intraday record; PetSmart considers sale 1:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 8:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 8:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 5:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 3:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 9:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 7:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 7:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 10:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 10:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 8:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 6:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 9:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 8:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 7:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 6:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 5:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 7:28 a.m. July 18, 2012 - MarketWatch.com
U.S. may end patents on DNA: report 1:13 p.m. Oct. 30, 2010 - Christopher Hinton
Monday's biggest gaining and declining stocks 4:51 p.m. Oct. 5, 2009 - MarketWatch

InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical 14 min ago - Seeking Alpha
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog 9:49 a.m. Aug. 27, 2014 - Zacks.com
The Biotech Stock With The Best One-Week Performance 2:46 p.m. Aug. 25, 2014 - benzinga.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog 4:55 p.m. Aug. 21, 2014 - Zacks.com
Perilous Reversal Stock: Amicus Therapeutics (FOLD) 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape 9:39 a.m. Aug. 21, 2014 - Zacks.com
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape 9:03 a.m. Aug. 21, 2014 - Zacks.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript) 3:43 p.m. Aug. 20, 2014 - Seeking Alpha
Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today 10:29 a.m. Aug. 20, 2014 - TheStreet.com
Stocks Hitting 52-Week Highs 9:15 a.m. Aug. 20, 2014 - benzinga.com
Amicus Fabry disease drug candidate successful in Phase 3 trial 7:27 a.m. Aug. 20, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:10 a.m. Aug. 20, 2014 - benzinga.com
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win 6:01 a.m. Aug. 20, 2014 - TheStreet.com
Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript 9:37 p.m. Aug. 7, 2014 - Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC 5:07 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape 8:44 a.m. Aug. 6, 2014 - Zacks.com
Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape 11:11 a.m. July 29, 2014 - Zacks.com
Applied Genetic Technologies Corporation (AGTC) Looks Strong as Stock Surges 15.3% - Tale of the Tape 8:44 a.m. July 28, 2014 - Zacks.com
Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape 8:44 a.m. July 25, 2014 - Zacks.com

Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 8:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 6:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Aug. 7, 2014 - GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014 4:01 p.m. July 31, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 8:50 a.m. July 30, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc. 2:55 p.m. July 7, 2014 - PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 6:30 a.m. July 3, 2014 - PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012 7:00 a.m. June 30, 2014 - GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum 8:20 a.m. June 4, 2014 - PR Newswire - PRF
Amicus Therapeutics to Present at UBS Global Healthcare Conference 4:10 p.m. May 14, 2014 - GlobeNewswire
Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. May 5, 2014 - GlobeNewswire
Dr. Farzad Mostashari to keynote SAS Health Analytics Executive Conference 10:30 a.m. May 5, 2014 - BusinessWire - BZX
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Amicus Therapeutics to Announce First Quarter 2014 10:01 a.m. May 1, 2014 - GlobeNewswire
Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011 6:01 a.m. April 29, 2014 - GlobeNewswire
Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference 4:39 p.m. March 27, 2014 - GlobeNewswire
Amicus Therapeutics Announces Full-Year 2013 Financial Results and Corporate Updates 5:01 p.m. March 3, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...